*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Through the Decision No 17-DCC-95 of 23 June 2017 Following the referral of the transaction by the European Commission, the French Competition Authority has authorised the acquisition of MédiPôle-Partenaires, the third largest private group of clinics in France, by the Elsan group, the second largest, subject to commitments of a structural nature on the one hand and of a behavioural nature on the other. In the light of its analysis, the Competition Authority comes to the conclusion that this approximation,
ALERT: MERGER - CLEARANCE - SOLE CONTROL - HORIZONTAL EFFECTS - VERTICAL EFFECTS - CONGLOMERATE EFFECTS - REFERAL TO NCA - COMMITMENTS
Clearance: The French Competition Authority clears the acquisition of sole control of a group of private hospitals by one of its competitors under conditions of behavioral and structural commitments (MédiPôle-Partenaires / Elsan)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.